Key result
DDX6 overexpression relieves DM1 mis-splicing and significantly reduces nuclear DMPK-mRNA foci, while its knockdown increases foci count and MBNL1 sequestration in the nucleus.
Population
Primary fibroblasts from myotonic dystrophy type 1 (DM1) patients and in vitro CUG-RNA models
Comparison
DDX6 overexpression and knockdown vs Control (endogenous DDX6 levels)
Design
Preclinical
Authors
Loading...
DDX6 modulation is hypothesis-generating for DM1; requires validation in human models before clinical consideration.
DDX6 unwinds CUG-repeat duplexes and remodels nuclear DMPK mRNP foci, suggesting a potential mechanism for normalizing pathogenic alternative splicing in myotonic dystrophy type 1.
Pettersson et al. (2014) studied Myotonic dystrophy type 1 (DM1). DDX6 overexpression and knockdown vs. Endogenous DDX6 levels was evaluated on DMPK-mRNA foci count, MBNL1 sequestration, and mis-splicing. DDX6 overexpression relieves DM1 mis-splicing and significantly reduces nuclear DMPK-mRNA foci, while its knockdown increases foci count and MBNL1 sequestration in the nucleus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: